Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

IMUN

Immune Therapeutics (PK) (IMUN)

Immune Therapeutics Inc (PK)
Date:
Sort by:
 Showing the most relevant articles for your search:USOTC:IMUN
DateTimeSourceHeadlineSymbolCompany
05/15/20245:15AMEdgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBUSOTC:IMUNImmune Therapeutics Inc (PK)
04/01/20247:05AMEdgar (US Regulatory)Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405USOTC:IMUNImmune Therapeutics Inc (PK)
11/14/20233:22PMEdgar (US Regulatory)Form 8-K - Current reportUSOTC:IMUNImmune Therapeutics Inc (PK)
11/14/202310:43AMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]USOTC:IMUNImmune Therapeutics Inc (PK)
11/02/20238:00AMEdgar (US Regulatory)Form 8-K - Current reportUSOTC:IMUNImmune Therapeutics Inc (PK)
10/24/20238:00AMEdgar (US Regulatory)Form 8-K - Current reportUSOTC:IMUNImmune Therapeutics Inc (PK)
09/14/20238:00AMEdgar (US Regulatory)Form 8-K - Current reportUSOTC:IMUNImmune Therapeutics Inc (PK)
09/13/20234:16PMEdgar (US Regulatory)Form 8-K - Current reportUSOTC:IMUNImmune Therapeutics Inc (PK)
08/18/20235:02AMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]USOTC:IMUNImmune Therapeutics Inc (PK)
08/14/20239:03AMEdgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBUSOTC:IMUNImmune Therapeutics Inc (PK)
04/20/20238:02AMEdgar (US Regulatory)Current Report Filing (8-k)USOTC:IMUNImmune Therapeutics Inc (PK)
04/10/20231:48PMEdgar (US Regulatory)Annual Report (10-k)USOTC:IMUNImmune Therapeutics Inc (PK)
03/31/202311:03AMEdgar (US Regulatory)Notification That Annual Report Will Be Submitted Late (nt 10-k)USOTC:IMUNImmune Therapeutics Inc (PK)
03/06/20234:01PMEdgar (US Regulatory)Current Report Filing (8-k)USOTC:IMUNImmune Therapeutics Inc (PK)
01/12/20239:01AMEdgar (US Regulatory)Information Statements (revised) (prer14c)USOTC:IMUNImmune Therapeutics Inc (PK)
12/16/20223:33PMEdgar (US Regulatory)Proxy Statement - Other Information (preliminary) (pre 14c)USOTC:IMUNImmune Therapeutics Inc (PK)
12/15/20223:49PMEdgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)USOTC:IMUNImmune Therapeutics Inc (PK)
12/15/20223:48PMEdgar (US Regulatory)Initial Statement of Beneficial Ownership (3)USOTC:IMUNImmune Therapeutics Inc (PK)
11/14/202211:27AMEdgar (US Regulatory)Quarterly Report (10-q)USOTC:IMUNImmune Therapeutics Inc (PK)
11/09/20224:01PMEdgar (US Regulatory)Current Report Filing (8-k)USOTC:IMUNImmune Therapeutics Inc (PK)
10/12/20227:50AMEdgar (US Regulatory)Current Report Filing (8-k)USOTC:IMUNImmune Therapeutics Inc (PK)
09/27/20221:38PMEdgar (US Regulatory)Current Report Filing (8-k)USOTC:IMUNImmune Therapeutics Inc (PK)
08/31/20221:59PMEdgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)USOTC:IMUNImmune Therapeutics Inc (PK)
08/24/20224:17PMEdgar (US Regulatory)Quarterly Report (10-q)USOTC:IMUNImmune Therapeutics Inc (PK)
08/02/20229:48AMEdgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)USOTC:IMUNImmune Therapeutics Inc (PK)
07/22/20222:45PMEdgar (US Regulatory)Current Report Filing (8-k)USOTC:IMUNImmune Therapeutics Inc (PK)
07/07/20224:28PMEdgar (US Regulatory)Current Report Filing (8-k)USOTC:IMUNImmune Therapeutics Inc (PK)
06/03/20223:58PMEdgar (US Regulatory)Current Report Filing (8-k)USOTC:IMUNImmune Therapeutics Inc (PK)
05/03/20223:22PMEdgar (US Regulatory)Quarterly Report (10-q)USOTC:IMUNImmune Therapeutics Inc (PK)
11/12/20219:29AMEdgar (US Regulatory)Quarterly Report (10-q)USOTC:IMUNImmune Therapeutics Inc (PK)
 Showing the most relevant articles for your search:USOTC:IMUN